Connecting Innovation to Purpose

26 CRB-701: Summary M Emerging clinical safety and potential for superior therapeutic index Dose expansion has started (China); dose escalation in US Q1 2024 3rd generation ADC with improved linker stability-reduces MMAE in circulation

View entire presentation